Drug
Filgrastim
Filgrastim: highest development phase Phase 2, developed by Amgen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Amgen
Trials
| Drug | Phase | Indication |
|---|---|---|
| filgrastim NCT00072319 | Phase 2 | Breast Cancer |
Latest
No recent events.
Follow Filgrastim on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.